Gertraud Orend

6.8k total citations · 2 hit papers
78 papers, 5.3k citations indexed

About

Gertraud Orend is a scholar working on Immunology and Allergy, Cell Biology and Molecular Biology. According to data from OpenAlex, Gertraud Orend has authored 78 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Immunology and Allergy, 33 papers in Cell Biology and 25 papers in Molecular Biology. Recurrent topics in Gertraud Orend's work include Cell Adhesion Molecules Research (52 papers), Cellular Mechanics and Interactions (23 papers) and Immunotherapy and Immune Responses (8 papers). Gertraud Orend is often cited by papers focused on Cell Adhesion Molecules Research (52 papers), Cellular Mechanics and Interactions (23 papers) and Immunotherapy and Immune Responses (8 papers). Gertraud Orend collaborates with scholars based in France, Germany and Switzerland. Gertraud Orend's co-authors include Kim S. Midwood, Ruth Chiquet‐Ehrismann, Erkki Ruoslahti, Richard P. Tucker, Matthias Chiquet, Tony Hunter, Thomas Hussenet, Benoît Langlois, Caroline Spenlé and Nobumoto Watanabe and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Gertraud Orend

77 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease

2009 583 citations Kim S. Midwood, Gertraud Orend et al. profile →
Tenascin-C at a glance

2016 323 citations Kim S. Midwood, Richard P. Tucker et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gertraud Orend France	37	2.3k	1.9k	1.3k	1.3k	900	78	5.3k
Birgit Leitinger United Kingdom	38	2.0k 0.9×	2.7k 1.4×	1.5k 1.1×	1.1k 0.8×	767 0.9×	54	5.2k
Nancy Boudreau United States	34	2.9k 1.3×	1.2k 0.7×	908 0.7×	920 0.7×	482 0.5×	65	5.4k
Beate Eckes Germany	50	2.2k 1.0×	1.8k 0.9×	2.1k 1.5×	546 0.4×	818 0.9×	117	7.1k
Kayla J. Bayless United States	42	2.9k 1.3×	897 0.5×	1.3k 0.9×	554 0.4×	917 1.0×	100	5.7k
Alexandra Naba United States	30	2.1k 0.9×	791 0.4×	1.3k 1.0×	1.3k 1.0×	517 0.6×	54	5.5k
Goos N.P. van Muijen Netherlands	47	3.1k 1.3×	1.5k 0.8×	1.5k 1.1×	2.5k 1.9×	1.9k 2.1×	125	6.9k
Naohiko Koshikawa Japan	40	2.1k 0.9×	1.5k 0.8×	864 0.6×	1.6k 1.2×	438 0.5×	102	4.9k
Randall H. Kramer United States	51	3.5k 1.5×	3.4k 1.8×	2.1k 1.6×	1.3k 1.0×	714 0.8×	101	7.1k
Stephen L. Nishimura United States	43	2.2k 0.9×	1.5k 0.8×	598 0.4×	938 0.7×	1.2k 1.4×	80	6.0k
Caroline H. Damsky United States	37	3.8k 1.7×	3.1k 1.6×	2.1k 1.6×	1.0k 0.8×	1.4k 1.6×	53	7.9k

Countries citing papers authored by Gertraud Orend

Since Specialization

Citations

This map shows the geographic impact of Gertraud Orend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gertraud Orend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gertraud Orend more than expected).

Fields of papers citing papers by Gertraud Orend

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gertraud Orend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gertraud Orend. The network helps show where Gertraud Orend may publish in the future.

Co-authorship network of co-authors of Gertraud Orend

This figure shows the co-authorship network connecting the top 25 collaborators of Gertraud Orend. A scholar is included among the top collaborators of Gertraud Orend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gertraud Orend. Gertraud Orend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sostoa, Jana de, Eliana Marinari, Valérie Widmer, et al.. (2025). Targeting the extracellular matrix with Tenascin-C-specific CAR T cells extends survival in preclinical models of glioblastoma. Journal for ImmunoTherapy of Cancer. 13(11). e011382–e011382.

Kaur, Amanpreet, Caroline Spenlé, Emmanuel Donnadieu, et al.. (2024). Targeting the MAtrix REgulating MOtif abolishes several hallmarks of cancer, triggering antitumor immunity. Proceedings of the National Academy of Sciences. 121(42). e2404485121–e2404485121. 5 indexed citations

Bouhaouala‐Zahar, Balkiss, et al.. (2024). Tenascin-C targeting strategies in cancer. Matrix Biology. 130. 1–19. 8 indexed citations

Gschwandtner, Martha, Claire Deligne, Thomas Loustau, et al.. (2023). Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2. International Journal of Molecular Sciences. 24(9). 8365–8365. 3 indexed citations

Fayçal, Chérine Abou, André Oszwald, Miguel Cosenza‐Contreras, et al.. (2022). An adapted passive model of anti-MPO dependent crescentic glomerulonephritis reveals matrix dysregulation and is amenable to modulation by CXCR4 inhibition. Matrix Biology. 106. 12–33. 6 indexed citations

Murdamoothoo, Devadarssen, Zhen Sun, Alev Yılmaz, et al.. (2021). Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression. EMBO Molecular Medicine. 13(6). e13270–e13270. 44 indexed citations

Deligne, Claire, Devadarssen Murdamoothoo, Martha Gschwandtner, et al.. (2020). Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype. Cancer Immunology Research. 8(3). 368–382. 48 indexed citations

Navarro‐Lérida, Inmaculada, Juan Antonio López, Inés Martín-Padura, et al.. (2020). ECM deposition is driven by caveolin-1–dependent regulation of exosomal biogenesis and cargo sorting. The Journal of Cell Biology. 219(11). 79 indexed citations

Murdamoothoo, Devadarssen, Zakaria Benlasfar, Ruth Chiquet‐Ehrismann, et al.. (2020). Generation and characterization of dromedary Tenascin-C and Tenascin-W specific antibodies. Biochemical and Biophysical Research Communications. 530(2). 471–478. 6 indexed citations

10.

Mammadova‐Bach, Elmina, Tristan Rupp, Caroline Spenlé, et al.. (2018). Laminin α1 orchestrates VEGFA functions in the ecosystem of colorectal carcinoma. Biology of the Cell. 110(8). 178–195. 16 indexed citations

11.

Sun, Zhen, Anja Schwenzer, Tristan Rupp, et al.. (2017). Tenascin-C Promotes Tumor Cell Migration and Metastasis through Integrin α9β1–Mediated YAP Inhibition. Cancer Research. 78(4). 950–961. 82 indexed citations

12.

Spenlé, Caroline, Falk Saupe, Kim S. Midwood, et al.. (2015). Tenascin-C: Exploitation and collateral damage in cancer management. Cell Adhesion & Migration. 9(1-2). 141–153. 53 indexed citations

13.

Obberghen‐Schilling, Ellen Van, et al.. (2011). Fibronectin and tenascin-C: accomplices in vascular morphogenesis during development and tumor growth. The International Journal of Developmental Biology. 55(4-5). 511–525. 91 indexed citations

14.

Midwood, Kim S., Thomas Hussenet, Benoît Langlois, & Gertraud Orend. (2011). Advances in tenascin-C biology. Cellular and Molecular Life Sciences. 68(19). 3175–3199. 262 indexed citations

15.

Edwards, Malia M., Elmina Mammadova‐Bach, Fabien Alpy, et al.. (2010). Mutations in Lama1 Disrupt Retinal Vascular Development and Inner Limiting Membrane Formation. Journal of Biological Chemistry. 285(10). 7697–7711. 67 indexed citations

16.

Lange, Katrin, Martial Kammerer, Falk Saupe, et al.. (2008). Combined Lysophosphatidic Acid/Platelet-Derived Growth Factor Signaling Triggers Glioma Cell Migration in a Tenascin-C Microenvironment. Cancer Research. 68(17). 6942–6952. 36 indexed citations

17.

Lange, Katrin, Martial Kammerer, Monika E. Hegi, et al.. (2007). Endothelin Receptor Type B Counteracts Tenascin-C–Induced Endothelin Receptor Type A–Dependent Focal Adhesion and Actin Stress Fiber Disorganization. Cancer Research. 67(13). 6163–6173. 56 indexed citations

18.

Baumann, Petra, Natascha Cremers, Frans G. M. Kroese, et al.. (2005). CD24 Expression Causes the Acquisition of Multiple Cellular Properties Associated with Tumor Growth and Metastasis. Cancer Research. 65(23). 10783–10793. 279 indexed citations

19.

Ruiz, Christian, Wentao Huang, Monika E. Hegi, et al.. (2004). Differential Gene Expression Analysis Reveals Activation of Growth Promoting Signaling Pathways by Tenascin-C. Cancer Research. 64(20). 7377–7385. 76 indexed citations

20.

Orend, Gertraud, Tony Hunter, & Erkki Ruoslahti. (1998). Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Oncogene. 16(20). 2575–2583. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact